| 2024 | 2023 | 2022 | 2021 |
|---|
| Revenues | 2,017.89 | 1,659.31 | 1,538.21 | 1,216.41 |
| Expenses | 1,916.05 | 1,558.59 | 1,389.82 | 1,113.73 |
| Net Profit (Loss) | 78.26 | 74.68 | 118.23 | 79.66 |
| Assets | 1,499.06 | 1,382.35 | 1,288.19 | 1,118.30 |
| Liabilities | 493.23 | 414.29 | 346.20 | 252.41 |
| Shareholders' Equity | 1,005.82 | 968.05 | 941.99 | 865.89 |
| Operating | 88.76 | 91.26 | 136.20 | 85.18 |
| Investing | -171.89 | 177.28 | -624.51 | -14.75 |
| Financing | -83.01 | -80.08 | -70.34 | 599.72 |
| EPS (Baht) | 0.29 | 0.27 | 0.43 | 0.39 |
| GP Margin (%) | 23.51 | 23.06 | 24.76 | 23.05 |
| NP Margin (%) | 3.88 | 4.50 | 7.69 | 6.55 |
| D/E Ratio (x) | 0.49 | 0.43 | 0.37 | 0.29 |
| ROE (%) | 7.93 | 7.82 | 13.08 | 16.08 |
| ROA (%) | 7.08 | 7.50 | 12.33 | 13.54 |
The Group aims to expand its branch continuously, targeting Bangkok and its vicinity due to the high market value. The target is to open 14 new branches in 2024. In addition, the Group also plans to launch innovative products under its own brands and expand its distribution channels.
- Aim to operate with fairness, legitimacy, and transparency.
- Strictly comply with the law and regulations.
- Operate in consistent with labor law and concerns regarding human rights.
- Show responsibility to customers by providing high quality products and customer services, with accurate and updated information, and keeping client confidentiality.
- Implement a green campaign by reducing usage of plastic bags and paper boxes. Implementing ERP systems to reduce paper usage. The Group initiated a pioneering project, by applying e-tax to business partners, in order to reduce paper use, for partners who are ready for the transformation.
- Place its importance on a healthy community and support sustainable development. The Group has participated in diverse activities in various aspects such as public health, education, and religion.
- Join "Recycle Medicine Blister Pack Saving the World" project from July 9 to December 31, 2024 and contribute to transform waste into social good.
- Be part of the "Needle Thread for Help" campaign by iRedcross starting from September 12, 2024, to support Parkinson's disease diagnosis and care.
The Group invests in pharmacy chains and collaborative research with external teams to commercialize innovative health products. It owns four pharmacy brands with 64 branches in Bangkok and its vicinity. The Group also has two innovative product brands: 'Prime', dietary supplement, and 'Besuto', health and hygiene products.
In 2024, the Group achieved sales revenue of 1,977.09 million baht, growing by 20.88% YOY. All product categories experienced revenue growth, with the highest growth seen in personal healthcare leading at 36.24% YOY, followed by medical food at 24.35% YOY. This aligns with the company's strategic focus on expanding its personal healthcare segment. Other income rose significantly by 71.67% YOY to 40.81 million baht, driven by branch expansion and sales space increase. This includes a 6.45 million baht profit from the sale of non-current assets held for sale - land with an unused warehouse. In 2024, the Group’s gross margin improved slightly to 23.51% from 23.06% in 2023. However, net profit increased by only 4.80% YOY. This was due to a 41.05% rise in distribution costs compared to 2023, primarily caused by expenses related to operating new branches. Fixed costs, including personnel costs, rent, and depreciation, accounted for 89.73% of its distribution costs.
- As of 31 Dec 2024, the Group had a total of 64 branches, by adding 14 branches in 2024 in Bangkok and its vicinity.
- Certified as Accredited Pharmacy by The Office of Community Pharmacy Accreditation (Thailand) to legitimately join the National Health Security System Program or the so-call "Golden Card" 30 Baht health care scheme.
- VAT REFUND FOR TOURISTS is available in all branches.
- Since founding the drugstore 30 years ago, the Group has sourced from two major distributors. The partnership has gone well. However, the Group has regularly reviewed new suppliers to ensure it secures sufficient products.
- In terms of competition risk, the Group focuses on expanding branches to strategic locations in Bangkok and having pharmacists stationed at all branches to guarantee superior quality of services.
- The Group is widely recognized in pharmacist professional group, as it has been offering internship programs for pharmaceutical students from leading universities for years. This has efficiently mitigated the risk of pharmacist shortage.
- Gold Medal for the invention Prime B0051 plus at the 2021 Japan Design, Idea & Invention Expo, August 18-20, 2021
- Silver Medal for the Invention Innovation Entitled: BESUTO-12 at the iCAN 2020 (Toronto, Canada), August 29, 2020
- Special Award in recognition of excellent invention/innovation of BESUTO-12 at the iCAN 2020 (Canada), August 29, 2020
- Silver Medal for SPECIAL EDITION 2022 from Cell Matrix Technology Prime VISON Product - INVENTION GENEVA EVALUATION DAYS, March 28, 2022
- Gold Medal for the invention Prime MOVX2 -2022 Japan Design, Idea & Invention Expo, July 1-3, 2022
- Gold Medal for the invention Prime KIN - 2024 Japan Design, Idea & Invention Expo, July 5-7, 2024
- PRIX EIFFEL 2024 Gold Medal Award; Canadian Special Award of Excellence for a special recognition of the excellent invention + innovation; and WIIPA Special Award in recognition of the outstanding invention for Prime Bioenhanz at the Prix International Invention and Innovation Contest (Paris, France) November 12-13, 2024
| as of 30/12/24 | HL | SERVICE | mai |
|---|---|---|---|
| P/E (X) | 36.14 | 82.27 | 41.84 |
| P/BV (X) | 2.85 | 1.84 | 1.55 |
| Dividend yield (%) | 1.47 | 2.77 | 2.47 |
| 30/12/24 | 28/12/23 | 30/12/22 | |
|---|---|---|---|
| Market Cap (MB) | 2,774.40 | 2,828.80 | 6,691.20 |
| Price (B/Share) | 10.20 | 10.40 | 24.60 |
| P/E (X) | 36.14 | 35.81 | 62.92 |
| P/BV (X) | 2.85 | 3.02 | 7.38 |